PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 105 filers reported holding PULMONX CORP in Q3 2022. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432,827 | -21.2% | 41,900 | 0.0% | 0.00% | – |
| Q2 2023 | $549,309 | +17.3% | 41,900 | 0.0% | 0.00% | – |
| Q1 2023 | $468,442 | +51.8% | 41,900 | +14.5% | 0.00% | – |
| Q4 2022 | $308,538 | -30.0% | 36,600 | +38.1% | 0.00% | – |
| Q3 2022 | $441,000 | -1.1% | 26,500 | -12.5% | 0.00% | – |
| Q2 2022 | $446,000 | -40.7% | 30,300 | 0.0% | 0.00% | – |
| Q1 2022 | $752,000 | -22.6% | 30,300 | 0.0% | 0.00% | – |
| Q4 2021 | $972,000 | -10.8% | 30,300 | 0.0% | 0.00% | – |
| Q3 2021 | $1,090,000 | -18.5% | 30,300 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $1,337,000 | +151.8% | 30,300 | +161.2% | 0.00% | – |
| Q1 2021 | $531,000 | -16.4% | 11,600 | +26.1% | 0.00% | – |
| Q4 2020 | $635,000 | – | 9,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |